Dr Reddy's Laboratories share price settles at ₹1,201; September 25 stock update

Key Takeaways

• Dr Reddy's Laboratories ended at ₹1,201, up ₹0.60 or 0.05%, after moving through a narrow ₹15 range between ₹1,193 and ₹1,208. 
• The close remained above its 50-day DMA of ₹1,190.70 but below the 100-day and 200-day averages. 
• One-month performance was positive at 0.92%, while three months, six months and one year remained negative. 

Dr Reddy's Laboratories share price closed September 25 at ₹1,201, up ₹0.60 or 0.05%. The previous close was ₹1,200 and the stock opened at ₹1,205. It reached ₹1,208 at the high and ₹1,193 at the low. The full session range measured ₹15, with the closing price ₹8 above the low and ₹7 below the high. 

The finish was almost exactly midway within that narrow range. Volume reached 1,029,882 shares, while market capitalisation stood at ₹100,245 crore. The stock ended ₹4 below its opening price despite recording a marginal positive change from the preceding close. 

The moving-average placement was mixed. The 50-day DMA was ₹1,190.70, putting the closing price ₹10.30 above it. The 100-day DMA stood at ₹1,215.50, or ₹14.50 above the finish. The 200-day DMA was ₹1,235, leaving a ₹34 difference. The shortest and longest averages were ₹44.30 apart. 

Across 52 weeks, Dr Reddy's had traded between ₹1,101 and ₹1,415. The ₹1,201 close was ₹100 above the annual low and ₹214 below the high. The full annual span measured ₹314. 

The return periods were mostly negative. One month stood at 0.92%, the only positive figure among the four. Three months was -9.59%, six months -4.65% and one year -7.48%. The difference between the one-month and three-month readings was 10.51 percentage points. 

The daily session itself remained compact: only ₹15 separated the high and low, while the close was nearly equidistant from both. The 50-day DMA was also relatively close, sitting ₹10.30 below the finish. By contrast, the 200-day average remained ₹34 above the closing price.